Alterity Therapeutics (ATHE) Total Debt (2011 - 2015)
Alterity Therapeutics (ATHE) recorded quarterly Total Debt of $424.62 in Q4 2015, up 4451.55% quarter-over-quarter from $9.33 in Q2 2015, and down 99.49% on a YoY basis from $83745.0 in Q4 2014.
Alterity Therapeutics (ATHE) Total Debt (2011 - 2015) Analysis & Trends
Alterity Therapeutics' Total Debt history runs 4 years deep, the most recent figure standing at $424.62 for Q4 2015.
- In Q4 2015, Total Debt fell 99.49% year-over-year to $424.62; the TTM figure through Dec 2015 stood at $424.62 (down 99.49% YoY), while the FY2015 annual figure was $12076.0, down 85.58% from the prior year.
- Total Debt was $424.62 for Q4 2015 at Alterity Therapeutics, up from $9.33 in the prior quarter.
- In the past five years, Total Debt ranged from a high of $377763.0 in Q2 2011 to a low of $9.33 in Q2 2015.
- Historically, Total Debt has averaged $189657.1 across 4 years, with a median of $210152.2 in 2011.
- The sharpest annual moves came in 2012 and 2015: Total Debt decreased 10.14% in 2012, then slumped 99.49% in 2015.
- A 4-year view of Total Debt shows it stood at $336559.4 in 2011, then grew by 0.86% to $339441.3 in 2012, then sank by 75.33% to $83745.0 in 2014, then plunged by 99.49% to $424.62 in 2015.
- The last three Total Debt figures came in at $424.62 (Q4 2015), $9.33 (Q2 2015), and $83745.0 (Q4 2014), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 319.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn | 1.99 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2015 | 424.62 |
| Jun 30, 2015 | 9.33 |
| Dec 31, 2014 | 83,745.00 |
| Jun 30, 2012 | 339,441.30 |
| Dec 31, 2011 | 336,559.41 |
| Jun 30, 2011 | 377,763.00 |